Loading: 100%
BAXTER INTERNATIONAL INC logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter Deerfield, United States of AmericaDeerfield, United States of Americano data available
Employees 48,000 (as per Q1 2017)no data available
Sector Medical Instruments & Equipmen, HealthcareMedical Instruments & Equipmen, Healthcareno data available
Ticker BAXno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 174048566472
datesClosing price (adj.)
13.10.201762.82
11.10.201762.01
04.10.201762.90
27.09.201762.46
20.09.201764.28
13.09.201764.61
06.09.201762.53
30.08.201761.48
23.08.201761.29
16.08.201761.20
09.08.201759.86
02.08.201759.35
26.07.201761.06
19.07.201762.29
12.07.201761.12
05.07.201760.55
27.06.201760.53
20.06.201759.72
13.06.201757.73
06.06.201759.24
30.05.201759.04
23.05.201757.61
16.05.201757.28
09.05.201755.84
02.05.201755.39
25.04.201752.93
18.04.201752.45
11.04.201752.69
04.04.201752.10
28.03.201751.62
21.03.201751.13
14.03.201751.63
07.03.201750.77
28.02.201750.52
21.02.201749.57
14.02.201748.58
07.02.201748.21
31.01.201747.54
24.01.201745.49
17.01.201746.16
10.01.201746.15
03.01.201744.09
27.12.201644.03
19.12.201644.29
12.12.201644.64
05.12.201643.55
28.11.201646.11
21.11.201646.56
14.11.201644.54
07.11.201647.11
31.10.201647.08
24.10.201647.92
17.10.201646.86
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
62.82n/a
Market Capitalisation
in million USD
34,153n/a
Enterprise Value
in million USD
34,071n/a
Common Shares Outstanding
as per Apr 30, 2017
543,669,114n/a
Preferred Shares Outstanding
as per Apr 30, 2017
n/a
Average Basic Shares Outstanding
TTM
544,000,000n/a
Average Diluted Shares Outstanding
TTM
550,750,000n/a
Index Membership
n/a
Business Summary
Baxter International Inc operates in the healthcare industry. It provides renal and hospital products such as infusion systems and systems, parenteral nutrition therapies, and biosurgery products.
no data available
Key Financials & Ratios (all figures TTM as per Mar 31, 2017, million USD, full statements further below)
Profit & Loss
Revenues 10,263n/a
Gross Profit 4,187n/a
Operating Income 880n/a
EBITDA 1,685n/a
Net Profit 1,857n/a
Balance Sheet
Cash and Cash Equivalents 2,858n/a
Receivables 0n/a
Total Current Assets 6,633n/a
PP&E 4,274n/a
Total Assets 15,659n/a
Accounts Payable 0n/a
Current Debt 3n/a
Total Current Liabilities 2,438n/a
Long-Term Debt 2,784n/a
Total Liabilities 6,984n/a
Total Equity 8,675n/a
Cash Flow
Depreciation & Amortisation 805n/a
Change in Working Capital 133n/a
Operating Cash Flow 2,176n/a
Net Change in PP&E and Intangibles -658n/a
Investing Cash Flow -631n/a
Dividends Paid -275n/a
Financing Cash Flow -871n/a
Total Change in Cash 647n/a
Free Cash Flow 1,059n/a
Profitability Ratios
Gross Margin 40.8%n/a
Operating Margin 8.6%n/a
Net Profit Margin 18.1%n/a
Return on Equity 21.4%n/a
Return on Assets 11.9%n/a
Per Share Figures
Basic EPS 3.41n/a
Diluted EPS 3.37n/a
Sales per Share 18.87n/a
Book Value per Share 15.97n/a
FCF per Share 1.95n/a
Dividends per Share 0.51n/a
Price Multiples
Price to Earnings Ratio 18.40n/a
Price to Sales Ratio 3.33n/a
Price to Book Value 3.94n/a
Price to Free Cash Flow 32.27n/a
Valuation Metrics
EV/EBITDA 20.22n/a
EV/Sales 3.32n/a
Book to Market Value 0.25n/a
Other Ratios
Current Ratio 272.1%n/a
Liabilities to Equity Ratio 80.5%n/a
Debt to Assets Ratio 17.8%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
11,263
12,348
12,562
12,843
13,893
13,936
9,413
10,719
9,968
10,163
Sales & Services Revenue
0
0
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
0
0
Cost of revenue
-5,744
-6,218
-6,037
-6,885
-6,847
-6,802
-5,251
-6,138
-5,822
-6,053
Cost of Goods & Services
0
0
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
0
0
Gross Profit
5,519
6,130
6,525
5,958
7,046
7,134
4,162
4,581
4,146
4,110
Other Operating Income
0
0
0
0
0
0
0
0
0
0
Operating Expenses
-3,281
-3,566
-3,648
-3,822
-4,100
-4,364
-3,666
-3,925
-3,697
-3,386
Selling, General & Administrative
-2,521
-2,698
-2,731
-2,907
-3,154
-3,283
-3,084
-3,315
-3,094
-2,739
Selling & Marketing
0
0
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
0
0
Research & Development
-760
-868
-917
-915
-946
-1,081
-582
-610
-603
-647
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
0
0
0
Operating Income (Loss)
2,238
2,564
2,877
2,136
2,946
2,770
496
656
449
724
Non-Operating Income (Loss)
-40
-102
-143
-246
-137
68
-121
-166
-21
4,230
Interest Expense, net
-22
-76
-98
-87
-54
-87
-128
-145
-126
-66
Interest Expense
0
0
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
-18
-26
-45
-159
-83
155
7
-21
105
4,296
Pretax Income (Loss), Adjusted
2,198
2,462
2,734
1,890
2,809
2,838
375
490
428
4,954
Abnormal Gains (Losses)
-70
0
0
0
0
0
0
0
0
0
Acquired In-Process R&D
0
0
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
0
0
Pretax Income (Loss)
2,128
2,462
2,734
1,890
2,809
2,838
375
490
428
4,954
Income Tax (Expense) Benefit, net
-407
-437
-519
-463
-553
-555
-60
-33
-35
12
Current Income Tax
0
0
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
1,721
2,025
2,215
1,427
2,256
2,283
315
457
393
4,966
Net Extraordinary Gains (Losses)
0
0
0
0
0
43
1,697
2,040
575
-1
Discontinued Operations
0
0
0
0
0
43
1,697
2,040
575
-1
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
1,721
2,025
2,215
1,427
2,256
2,326
2,012
2,497
968
4,965
Minority Interest
-14
-11
-10
-7
-32
0
0
0
0
0
Net Income
1,707
2,014
2,205
1,420
2,224
2,326
2,012
2,497
968
4,965
Preferred Dividends
0
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
1,707
2,014
2,205
1,420
2,224
2,326
2,012
2,497
968
4,965
Remarks
restated on Feb 23, 2010 n/a
calculated values,
restated on Feb 23, 2011 n/a
calculated values,
restated on Feb 23, 2012 n/a
calculated values,
restated on Feb 21, 2013 n/a
calculated values,
restated on Feb 21, 2014 n/a
calculated values,
restated on Feb 26, 2015 n/a
calculated values,
restated on Feb 26, 2016 n/a
calculated values,
restated on Feb 23, 2017 n/a
calculated values,
restated on Feb 23, 2017 n/a
calculated values,
restated on Feb 23, 2017 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
2,131
2,786
2,685
2,905
3,270
2,733
2,925
7,361
2,801
Cash & Cash Equivalents
n/a
2,131
2,786
2,685
2,905
3,270
2,733
2,925
2,213
2,801
Short Term Investments
n/a
0
0
0
0
0
0
0
5,148
0
Accounts & Notes Receivable
n/a
1,980
2,302
2,265
2,420
2,425
2,911
1,884
1,731
1,691
Accounts Receivable, Net
n/a
0
0
0
0
0
0
0
0
0
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
0
0
Inventories
n/a
2,361
2,557
2,371
2,628
2,803
3,499
1,577
1,604
1,430
Raw Materials
n/a
0
0
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
0
0
Other Short Term Assets
n/a
676
626
668
697
762
1,052
3,776
1,100
652
Prepaid Expenses
n/a
425
400
345
402
418
548
478
855
602
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
3,298
245
50
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
0
0
Income Taxes Receivable
n/a
251
226
323
295
344
504
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
0
0
0
0
0
0
Total Current Assets
n/a
7,148
8,271
7,989
8,650
9,260
10,195
10,162
11,796
6,574
Property, Plant & Equipment, Net
n/a
4,609
5,159
5,260
5,525
6,098
7,832
4,434
4,386
4,289
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
0
0
Other Long Term Assets
n/a
3,648
3,924
4,240
4,898
5,032
7,197
11,542
4,780
4,683
Intangible Assets
n/a
0
0
0
0
0
0
0
0
0
Goodwill
n/a
1,654
1,825
2,015
2,317
2,502
4,205
2,927
2,687
2,595
Other Intangible Assets
n/a
390
513
500
826
814
2,294
1,620
1,349
1,111
Prepaid Expense
n/a
0
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
1,604
1,586
1,725
1,755
1,716
698
6,995
744
977
Total Noncurrent Assets
n/a
8,257
9,083
9,500
10,423
11,130
15,029
15,976
9,166
8,972
Total Assets
n/a
15,405
17,354
17,489
19,073
20,390
25,224
26,138
20,962
15,546
Liabilities and owners' equity
Payables & Accruals
n/a
3,241 3241000000
3,753 3753000000
4,017 4017000000
4,411 4411000000
4,409 4409000000
4,208 4208000000
2,677 2677000000
2,666 2666000000
2,612 2612000000
Accounts Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Debt
n/a
394 394000000
711 711000000
24 24000000
446 446000000
350 350000000
1,040 1040000000
1,698 1698000000
2,585 2585000000
3 3000000
Short Term Borrowings
n/a
388 388000000
29 29000000
15 15000000
256 256000000
27 27000000
181 181000000
913 913000000
1,775 1775000000
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
6 6000000
682 682000000
9 9000000
190 190000000
323 323000000
859 859000000
785 785000000
810 810000000
3 3000000
Other Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
1,662 1662000000
499 499000000
129 129000000
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
336 336000000
453 453000000
126 126000000
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
1,326 1326000000
46 46000000
3 3000000
Total Current Liabilities
n/a
3,635 3635000000
4,464 4464000000
4,041 4041000000
4,857 4857000000
4,759 4759000000
5,248 5248000000
6,037 6037000000
5,750 5750000000
2,744 2744000000
Long Term Debt
n/a
3,362 3362000000
3,440 3440000000
4,363 4363000000
4,749 4749000000
5,580 5580000000
8,126 8126000000
7,331 7331000000
3,922 3922000000
2,779 2779000000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
2,117 2117000000
2,030 2030000000
2,289 2289000000
2,639 2639000000
3,073 3073000000
3,364 3364000000
4,614 4614000000
2,425 2425000000
1,743 1743000000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
2,117 2117000000
2,030 2030000000
2,289 2289000000
2,639 2639000000
3,073 3073000000
3,364 3364000000
4,614 4614000000
2,425 2425000000
1,743 1743000000
Total Noncurrent Liabilities
n/a
5,479 5479000000
5,470 5470000000
6,652 6652000000
7,388 7388000000
8,653 8653000000
11,490 11490000000
11,945 11945000000
6,347 6347000000
4,522 4522000000
Total Liabilities
n/a
9,114 9114000000
9,934 9934000000
10,693 10693000000
12,245 12245000000
13,412 13412000000
16,738 16738000000
17,982 17982000000
12,097 12097000000
7,266 7266000000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
6,216 6216000000
6,366 6366000000
6,436 6436000000
6,466 6466000000
6,452 6452000000
6,501 6501000000
6,536 6536000000
6,585 6585000000
6,641 6641000000
Common Stock
n/a
683 683000000
683 683000000
683 683000000
683 683000000
683 683000000
683 683000000
683 683000000
683 683000000
683 683000000
Additional Paid in Capital
n/a
5,533 5533000000
5,683 5683000000
5,753 5753000000
5,783 5783000000
5,769 5769000000
5,818 5818000000
5,853 5853000000
5,902 5902000000
5,958 5958000000
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
-3,897 -3897000000
-4,741 -4741000000
-5,655 -5655000000
-6,719 -6719000000
-7,592 -7592000000
-7,914 -7914000000
-7,993 -7993000000
-7,646 -7646000000
-7,995 -7995000000
Retained Earnings
n/a
5,795 5795000000
7,343 7343000000
7,925 7925000000
9,429 9429000000
10,888 10888000000
11,852 11852000000
13,227 13227000000
9,683 9683000000
14,200 14200000000
Other Equity
n/a
-1,885 -1885000000
-1,777 -1777000000
-2,139 -2139000000
-2,591 -2591000000
-2,810 -2810000000
-1,976 -1976000000
-3,650 -3650000000
224 224000000
-4,556 -4556000000
Equity Before Minority Interest
n/a
6,229 6229000000
7,191 7191000000
6,567 6567000000
6,585 6585000000
6,938 6938000000
8,463 8463000000
8,120 8120000000
8,846 8846000000
8,290 8290000000
Minority Interest
n/a
62 62000000
229 229000000
229 229000000
243 243000000
40 40000000
23 23000000
36 36000000
19 19000000
-10 -10000000
Total Equity
n/a
6,291 6291000000
7,420 7420000000
6,796 6796000000
6,828 6828000000
6,978 6978000000
8,486 8486000000
8,156 8156000000
8,865 8865000000
8,280 8280000000
Total Liabilities & Equity
n/a
15,405 15405000000
17,354 17354000000
17,489 17489000000
19,073 19073000000
20,390 20390000000
25,224 25224000000
26,138 26138000000
20,962 20962000000
15,546 15546000000
Remarks restated on n/a restated on Feb 23, 2010 n/a restated on Feb 23, 2011 n/a restated on Feb 23, 2012 n/a restated on Feb 21, 2013 n/a restated on Feb 21, 2014 n/a restated on Feb 26, 2015 n/a restated on Feb 26, 2016 n/a restated on Feb 23, 2017 n/a restated on May 4, 2017 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
1,721
2,025
2,215
1,427
2,256
2,326
315
457
393
4,966
Net Income
1,721
2,025
2,215
1,427
2,256
2,326
2,012
2,497
968
4,965
Net Income From Discontinued Operations
0
0
0
0
0
0
-1,697
-2,040
-575
1
Other Adjustments
0
0
0
0
0
0
0
0
0
0
Depreciation & Amortization
581
631
638
685
670
712
635
792
759
800
Non-Cash Items
491
359
338
967
337
198
197
178
-13
-4,040
Stock-Based Compensation
136
146
140
120
119
130
122
126
126
115
Deferred Income Taxes
126
280
267
76
172
-17
-185
-117
-50
-302
Other Non-Cash Adjustments
229
-67
-69
771
46
85
260
169
-89
-3,853
Change in Working Capital
-488
-500
-282
-76
-446
-130
142
-273
114
-102
(Increase) Decrease in Accounts Receivable
-278
-98
-167
-122
-229
-41
16
-93
-4
15
(Increase) Decrease in Inventories
-211
-163
-60
20
-315
-129
-49
-143
-118
80
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
1
-239
-55
26
98
40
175
-37
236
-197
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
1,909
2,061
518
30
Cash from Operating Activities
2,305
2,515
2,909
3,003
2,817
3,106
3,198
3,215
1,771
1,654
Change in Fixed Assets & Intangibles
-692
-954
-1,014
-963
-960
-1,161
-706
-925
-911
-719
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
-692
-954
-1,014
-963
-960
-1,161
-706
-925
-911
-719
Net Change in Long Term Investment
0
0
0
0
0
0
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
387
-39
-132
-301
-467
-408
-3,642
4
50
-11
Net Cash from Divestitures
499
60
24
18
123
107
31
99
84
37
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
-112
-99
-156
-319
-590
-515
-3,673
-95
-34
-48
Other Investing Activities
0
0
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
-1,014
-621
-946
15
Cash from Investing Activities
-305
-993
-1,146
-1,264
-1,427
-1,569
-5,362
-1,542
-1,807
-715
Dividends Paid
-704
-546
-632
-688
-709
-804
-1,023
-1,095
-910
-268
Cash From (Repayment of) Debt
-51
-79
473
91
733
765
3,096
-113
2,507
-40
Cash From (Repayment of) Short Term Debt, net
0
200
-200
0
250
-250
0
875
-575
-300
Cash From (Repayment of) Long Term Debt, net
-51
-279
673
91
483
1,015
3,096
-988
3,082
260
Repayments of Long Term Debt
-635
-950
-199
-567
-23
-22
-540
-1,029
-3,786
-1,381
Cash From Long Term Debt
584
671
872
658
506
1,037
3,636
41
6,868
1,641
Cash From (Repurchase of) Equity
-1,855
-1,986
-1,216
-1,453
-1,583
-1,480
-913
-550
0
-292
Increase in Capital Stock
0
0
0
0
0
0
0
0
0
0
Decrease in Capital Stock
-1,855
-1,986
-1,216
-1,453
-1,583
-1,480
-913
-550
0
-292
Other Financing Activities
639
680
363
334
422
404
485
356
-2,078
276
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
-1,971
-1,931
-1,012
-1,716
-1,137
-1,115
1,645
-1,402
-481
-324
Net Cash Before Disc. Operations and FX
29
-409
751
23
253
422
-519
271
-517
615
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
0
0
Net Cash Before FX
29
-409
751
23
253
422
-519
271
-517
615
Effect of Foreign Exchange Rates
25
1
-96
-124
-33
-57
-18
-79
-195
-27
Net Changes in Cash
54
-408
655
-101
220
365
-537
192
-712
588
Remarks
restated on Feb 23, 2010 n/a
calculated values,
restated on Feb 23, 2011 n/a
calculated values,
restated on Feb 23, 2012 n/a
calculated values,
restated on Feb 21, 2013 n/a
calculated values,
restated on Feb 21, 2014 n/a
calculated values,
restated on Feb 26, 2015 n/a
calculated values,
restated on Feb 26, 2016 n/a
calculated values,
restated on Feb 23, 2017 n/a
calculated values,
restated on Feb 23, 2017 n/a
calculated values,
restated on Feb 23, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo